Sign In to Follow Application
View All Documents & Correspondence

Acylated Insulin Compound

Abstract: ABSTRACT The presently described compounds relate to the treatment of diabetes and/or hyperglycemia. More particularly, the described compounds relate to acylated insulin compounds that lower blood glucose, pharmaceutical compositions containing such compounds, therapeutic uses of such compounds, and an intermediate compound used to make the acylated insulin compounds.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
28 March 2024
Publication Number
45/2024
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
Parent Application

Applicants

ELI LILLY AND COMPANY
Lilly Corporate Center Indianapolis, Indiana United States of America 46285

Inventors

1. LIU, Wen
c/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288, United States of America
2. MEZO, Adam Robert
c/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288, United States of America
3. VALENZUELA, Francisco Alcides
c/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288, United States of America

Specification

Description:Please see the attachments , Claims:Please see the attachments

Documents

Application Documents

# Name Date
1 202418025057-STATEMENT OF UNDERTAKING (FORM 3) [28-03-2024(online)].pdf 2024-03-28
2 202418025057-Sequence Listing in txt [28-03-2024(online)].txt 2024-03-28
3 202418025057-Sequence Listing in PDF [28-03-2024(online)].pdf 2024-03-28
4 202418025057-REQUEST FOR EXAMINATION (FORM-18) [28-03-2024(online)].pdf 2024-03-28
5 202418025057-Proof of Right [28-03-2024(online)].pdf 2024-03-28
6 202418025057-POWER OF AUTHORITY [28-03-2024(online)].pdf 2024-03-28
7 202418025057-FORM-26 [28-03-2024(online)].pdf 2024-03-28
8 202418025057-FORM 18 [28-03-2024(online)].pdf 2024-03-28
9 202418025057-FORM 1 [28-03-2024(online)].pdf 2024-03-28
10 202418025057-DECLARATION OF INVENTORSHIP (FORM 5) [28-03-2024(online)].pdf 2024-03-28
11 202418025057-COMPLETE SPECIFICATION [28-03-2024(online)].pdf 2024-03-28
12 202418025057-FORM 3 [29-08-2024(online)].pdf 2024-08-29